STOCK TITAN

Mesa Laboratories, Inc. - MLAB STOCK NEWS

Welcome to our dedicated news page for Mesa Laboratories (Ticker: MLAB), a resource for investors and traders seeking the latest updates and insights on Mesa Laboratories.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Mesa Laboratories's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Mesa Laboratories's position in the market.

Rhea-AI Summary
Mesa Laboratories, Inc. announces the release of its second annual Environmental, Social, and Governance Program Brochure, showcasing its commitment to sustainability and transparency. The brochure highlights Mesa's acquisition of GKE, incorporation of greenhouse gas emissions data, and dedication to Protecting the Vulnerable®. The Company's ESG Taskforce and Board of Directors drive responsible business practices, positioning Mesa as a leader in global sustainability efforts.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.23%
Tags
none
-
Rhea-AI Summary
Mesa Laboratories, Inc. (MLAB) reported a 1.5% decrease in revenues for the third fiscal quarter of 2024 compared to the same period in 2023. The company's operating income decreased by 102%, but non-GAAP adjusted operating income excluding unusual items increased by 7.3% compared to the previous quarter. The Sterilization and Disinfection Control division saw a 4.8% organic decline in revenues, while the Calibration Solutions division experienced a 12.9% organic growth. Clinical Genomics and Biopharmaceutical Development divisions faced significant organic declines. Overall, Mesa Laboratories is navigating challenging market conditions and economic uncertainties.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.64%
Tags
earnings
-
Rhea-AI Summary
Mesa Laboratories, Inc. (MLAB) appoints Mark Capone to its Board of Directors, effective January 5, 2024. Capone, an accomplished life sciences executive, brings significant leadership and acquisitions experience. The Board aims to leverage Capone's insights for Mesa's growth strategy and value proposition to customers, employees, and shareholders.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.66%
Tags
management
News
Rhea-AI Summary
Mesa Laboratories, Inc. (NASDAQ:MLAB) declares regular quarterly dividend of $0.16 per share of common stock
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.61%
Tags
dividends
-
Rhea-AI Summary
Mesa Laboratories, Inc. (NASDAQ:MLAB) completed the acquisition of GKE-GmbH's sterilization indicators business and its accredited, independent testing lab SAL GmbH on October 16th, 2023. They also acquired GKE's Chinese sales entity, Beijing GKE Science & Technology Co. LTD ('GKE China') on December 31, 2023. The acquisitions are expected to add €19-€20 million of revenues over the next 12 months and deliver mid-single digit organic revenues growth over the next several years. Gross profit as a percentage of revenues is expected to be in line with their existing SDC business, and adjusted operating income as a percentage of revenues is projected to approach 37%-40% over the next 12 months.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.59%
Tags
acquisition
-
Rhea-AI Summary
Mesa Laboratories, Inc. (NASDAQ:MLAB) will release its Q3 fiscal year 2024 financial results on February 5, 2024, at 8:00 A.M. Eastern time.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.12%
Tags
earnings
Rhea-AI Summary
Mesa Laboratories, Inc. announced its second fiscal quarter results for 2Q24. Revenues decreased by 9.5%, but increased by 5.0% compared to 1Q24. Non-GAAP core organic revenues decreased by 10.1%, but increased by 2.7% compared to 1Q24. Operating income decreased by 101.5%. The company implemented cost control actions expected to generate annual savings of approximately $2,000 starting in 3Q24.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.41%
Tags
earnings
-
News
Rhea-AI Summary
Mesa Laboratories, Inc. declares quarterly dividend of $0.16 per share of common stock.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.52%
Tags
dividends
-
Rhea-AI Summary
Mesa Laboratories, Inc. (NASDAQ:MLAB) to release Q2 FY2024 financial results on November 6, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
earnings
Rhea-AI Summary
Mesa Labs commits to calculate and disclose greenhouse gas emissions by August 2024 Annual Meeting of Shareholders as part of its sustainability roadmap. CEO emphasizes focus on improving efficiency and reducing waste and energy consumption. This will provide a comprehensive view of the Company's emissions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.57%
Tags
none
Mesa Laboratories, Inc.

Nasdaq:MLAB

MLAB Rankings

MLAB Stock Data

578.51M
5.19M
5.74%
91.67%
4.4%
Instruments and Related Products Manufacturing for Measuring, Displaying, and Controlling Industrial Process Variables
Manufacturing
Link
United States
Lakewood

About MLAB

mesa laboratories, inc., develops, manufactures and markets high-quality process validation, monitoring and calibration instruments and consumables worldwide. mesa offers quality data loggers for monitoring temperature, humidity, and pressure and biological indicators (bis) for medical device and pharmaceutical manufacturing sterilization monitoring. the datatrace data loggers and mesa bis are available to monitor and validate applications including steam and eo sterilization, autoclave validation, incubators, heat tunnels and more. mesa’s bi offering also includes bis for industrial use, hydrogen peroxide (h2o2), chlorine dioxide and more. the phoenix meter is a point-of-use dialysate qc meter used prior to each procedure. the 90xl meter is the industry standard for calibration of dialysis machines in the field. also available are industry leading nist-traceable calibration solutions. mesa also offers cap torque testers which are durable, reliable and computerized cap torque analyzers